Farxiga(dapagliflozin)

Type 2 diabetes; heart failure; chronic kidney disease.

1 DTP program

From $181.59/mo

1 platform

FDA-Approved Indications

Glycemic control in adults with type 2 diabetesHeart failure (HFrEF and HFpEF) to reduce CV death and hospitalizationChronic kidney disease to reduce eGFR decline, ESKD, and CV/renal death

Available direct-to-patient (DTP) programs

Sorted by price, lowest first. Always verify eligibility and pricing directly with the manufacturer.

Lowest price option

Self-pay cash (home delivery only)

via AZ Patient Direct · AstraZeneca

$181.59/mo

$181.59/30 tablets (home delivery only). Eligible patients via AZ&Me: as little as $0. HSA/FSA eligible.

Eligibility

Valid Rx required. US patients only. Home delivery only via ASPN Pharmacies / Medvantx. No retail pharmacy pickup at self-pay price.

Government eligibility determined during enrollment. Verify with manufacturer.

Visit Program

Last verified: Mar 2026

Not sure which Farxiga program fits your situation?

Find My Options